(Q39211836)
Statements
1 reference
Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity (English)
1 reference
Peter Flachenecker
1 reference
Thomas Henze
1 reference
Uwe K Zettl
1 reference
12 February 2014
1 reference
1 reference
71
1 reference
5-6
1 reference
271-279
1 reference
Identifiers
1 reference
1 reference